Use of chlorotoxin for targeting of primary brain tumors

Cancer Research

Volumn 58, Issue 21, 1998, Pages 4871-4879

  Soroceanu, Liliana ^a   Gillespie, Yancey ^b   Khazaeli, M B ^c   Sontheimer, Harald ^a,d  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham Heersink School of Medicine   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; CHLOROTOXIN; SCORPION VENOM; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GRADING; CELL HETEROGENEITY; CONTROLLED STUDY; DRUG SELECTIVITY; FEMALE; GLIA CELL; GLIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT; SCORPION;

ANIMALS; AUTORADIOGRAPHY; BRAIN NEOPLASMS; CHLORIDE CHANNELS; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IODINE RADIOISOTOPES; MICE; MICE, SCID; RADIOLIGAND ASSAY; SCORPION VENOMS; TUMOR CELLS, CULTURED;

EID: 0032211350     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Kurpad, S. N., Zhao, X. G., Wikstrand, C. J., Batra, S. K., McLendon, R. E., and Bigner, D. D. Tumor antigens in astrocytic gliomas. Glia, 15: 244-256, 1995.
2. Burger, P. C. Revising the World Health Organization (WHO) blue book - Histological Typing of Tumours of the Central Nervous System. J. Neuro-Oncol., 24: 3-7, 1995.
3. Zhang, H., Kelly, G., Zerillo, C., Jaworski, D. M., and Hockfield, S. Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion in vivo. J. Neurosci., 18: 2370-2376, 1998.
4. Murata, T., Obiri, N. I., Debinski, W., Purik, K. Structure of IL-13 receptor: analysis of subunit composition in cancer and immune cells, Biochem. Biophys. Res. Commun., 238: 90-94, 1997.
5. Ullrich, N., Gillespie, G. Y., and Sontheimer, H. Human astrocytoma cells express a unique chloride current. Neuroreport, 7: 1020-1024, 1996.
6. Ullrich, N., and Sontheimer, H. Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells. Am. J. Physiol. (Cell Physiol.), 270: C1511-C1521, 1996.
7. Ullrich, N., Bordey, A., Gillespie, G. Y., and Sontheimer, H. Expression of voltage-activated chloride currents in acute slices of human gliomas. Neurosci., 83: 1161-1173, 1998.
8. Ullrich, N., and Sontheimer, H. Cell cycle dependent expression of a glioma-specific chloride current: proposed link to cytoskeletal changes. Am. J. Physiol. (Cell Physiol.), 273: C1290-C1297, 1997.
9. Andreanski, S., Soroceanu, L., Flotte, E. R., Chou, J., Markert, J. M., Gillespie, Y. G., Roizman, B., and Whitley R. J. Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res., 57: 1502-1509, 1997.
10. Massague, J. Identification of receptors for the type-β transforming growth factor. Methods Enzymol., 146: 174-195, 1987.
11. Jentsch, T. J., Günther, W., Pusch, M., and Schwappach, B. Properties of voltage-gated chloride channels of the CIC gene family. J. Physiol., 482 (Suppl. P): 19S-25S, 1995.
12. DeBin, J. A., Maggio, J. E., and Strichartz, G. R. Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am. J. Physiol., 264: 361-369, 1993.
13. DeBin, J. A., Wood, M. R., Pfenninger, K. H., and Serichartz, G. R. A chloride channel reconstituted from fetal rat brain growth cones. J. Membr. Biol., 141: 7-19, 1994.
14. Lippens, G., Najib, J., Wodak, S. J., and Tartar, A. NMR sequential assignments and solution structure of chlorotoxin, a small scorpion toxin that blocks chloride channels. Biochemistry, 34: 13-21, 1995.
15. Williams, J. A., Wessels, B. W., Edwards, J. A., Kopher, K. A., Wanek, P. M., Wharam, M. D., Order, S. E., and Klein, J. L. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies. Cancer Res., 50 (Suppl.): 974s-979s, 1990.
16. 131I-monoclonal antibodies for the treatment of central system malignancies. Int. J. Radiat. Oncol. Biol. Phys., 31: 541-542, 1995.
17. 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats. Bioconjugate Chem., 8: 289-295, 1997.
18. Raben, D., Buchsbaum, D. J., Khazaeli, M. B. Rosenfeld, M. E., Gillespie, Y. G., Grizzle, W. E., Liu, T., and Curiel, D. T. Enhancement of radiolabeled antibody binding and tumor localization through adenoviral transduction of the human carcinoembryonic antigen gene. Gene Ther., 3: 567-580, 1996.
19. Buchsbaum, D. J., Nelson, L, Hanna, D., and Vallera, D. A. Human leukemia cell binding and killing by anti-CD5 radioimmunotoxins. Int. J. Radiat. Oncol. Biol. Phys., 13: 1701-1712, 1987.
20. Chamberlain, M. C, Barba, D., Kormanik, P., Berson, A. M., Saunders, W. M., and Shea, M. C. Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors. Arch. Neurol., 52: 162-167, 1995.
21. 131I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with sub-arachnoid communication: Phase 1 trial results. Clin. Cancer Res., 2: 963-972, 1996.
22. Tecce, R., Nicotra, M. R., Fraioli, R., Cuomo, M., Trizio, D., and Natali, P. G. Saporin 6 conjugated to monoclonal antibody selectively kills human melanoma cells. Melanoma Res., 1: 115-123, 1991.
23. Laske, D. W., Ilercil, O., Akbasak, A., Youle, R. J., and Oldfield, E. H. Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice. J. Neurosurg., 80: 520-526, 1994.